Feature Channels: Vaccines

• share
• favorite_border

A recent case of polio in the U.S. sounds the alarm for more vaccination.

• share
• favorite_border

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with cash incentives and if it is made by Moderna or Pfizer.

• share
• favorite_border

Infectious Disease experts at Ochsner Health in New Orleans reveal the top 10 myths about the flu and flu vaccines in 2022.

• share
• favorite_border

When the Biden administration announced COVID-19 vaccine mandates on Nov. 4 for businesses with 100 or more employees, protests erupted in cities across the U.S.

• share
• favorite_border

Monkeypox cases are on the rise in the U.S., stoking fear and confusion about the way the virus is spread, who is at risk and where to seek treatment.

• share
• favorite_border

A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

• share
• favorite_border

The remarkable effectiveness of mRNA vaccines against SARS-CoV-2 has generated much interest in synthetic mRNA therapeutics for treating and preventing disease. But some basic science questions have remained about whether the modified nucleotides used in the vaccines faithfully produce the protein products that they are designed to make.

• share
• favorite_border

• share
• favorite_border

New research from the Department of Psychological & Brain Sciences in Arts & Sciences indicates that fear-based messaging may result in mixed effects when it comes to public health.

• share
• favorite_border

Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does. Physician-scientists hope this growing body of evidence, highlighted today in an editorial in the peer-reviewed journal Neurology, will ease the minds of individuals still hesitant to be vaccinated.

• share
• favorite_border

As we approach the time of year when students switch from vacation mode to school mode, Johns Hopkins Children’s Center experts are available for interviews on a variety of back-to-school-related topics to share advice for a smooth start to the new school year.

• share
• favorite_border

Public health researchers from the University of California, Irvine identified several social media messaging strategies to educate young adults and their parents about evidence-based interventions around the human papillomaviruses (HPV). Their findings could help inform future health information social media campaigns, beyond the HPV vaccine, on the benefits of lifesaving interventions.

• share
• favorite_border

The World Health Organization and the White House have declared the growing monkeypox outbreak a public health emergency, with the Centers for Disease Control and Prevention recommending that people seek medical care immediately if they develop a new, unexplained skin rash or lesion on any part of their body that they think could be monkeypox.

• share
• favorite_border

“For too long, we've falsely assumed that polio has been eradicated in the U.S.,” says Katherine Foss, a professor and associate director of the School of Journalism & Strategic Media at Middle Tennessee State University. However, no cases doesn’t mean the virus has been eradicated, especially with polio still existing in the world.

• share
• favorite_border

The latest research and expert commentary on the monkeypox outbreak.

• share
• favorite_border

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects. Results in mouse models and human cells show promising results and pave the way for human clinical trials. The research, conducted in close collaboration with UT Health San Antonio, was published online in June in the journal Cancer Immunology, Immunotherapy.

• share
• favorite_border

In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose of a COVID-19 vaccine in England, the risk of myocarditis in unvaccinated individuals after COVID-19 infection was at least 11 times higher compared to people who developed myocarditis after receiving a COVID-19 vaccine or booster dose between December 1, 2020 and December 15, 2021, according to new research published today in the American Heart Association’s flagship, peer-reviewed journal Circulation.